Sprint Bioscience AB (5JA1)
Munich
Real-time Data
06:00 AM
Day's Range
0.280052 wk Range
0.0502Overview - 5JA1 - Sprint Bioscience AB
Key Statistics
Valuation
P/E (Trailing)
‪0.28‬
PEG Ratio
‪0.0053‬
Price / Book
‪0.27‬
Profitability
Profit Margin
‪92.17%‬
Operating Margin
‪55.13%‬
Return on Assets
‪67.12%‬
Return on Equity
‪76.97%‬
Ownership
Shares Outstanding
105.51M
Price stats
50-Day Avg
‪0.3512‬
200-Day Avg
‪0.2420‬
Peers - 5JA1 - Sprint Bioscience AB
Peer Comparison
Compared with companies in Biotechnology listed on Munich.
- 5JA1MunichSprint Bioscience AB+82.07%52-week change0.28P/E (Trailing)‪92.17%‬Profit Margin
- 0QFMunichModerna, Inc.+82.56%52-week change25.19P/E (Trailing)‪-141.42%‬Profit Margin
- 4E2MunichRelmada Therapeutics Inc.+86.82%52-week change-2.80P/E (Trailing)—Profit Margin
- 42ZMunichRevolution Medicines Inc.+82.82%52-week change-30.32P/E (Trailing)—Profit Margin
- B9B9P0MunichNovabay Pharmaceuticals Inc. R+80.00%52-week change-0.01P/E (Trailing)—Profit Margin
- 87EMunichDianthus Therapeutics Inc.+78.62%52-week change-22.50P/E (Trailing)—Profit Margin
- 5NRMunichNanobiotix S.A.+77.80%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 5JA1 - Sprint Bioscience AB
About
Sprint Bioscience AB is a biotechnology company specializing in the early stages of drug development. The company's primary function is to accelerate the discovery and development of novel oncology pharmaceuticals. Utilizing state-of-the-art technology platforms, Sprint Bioscience focuses on identifying and validating…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
